India's Commerce Secretary looks to change nation's image as hub for spurious drugs

12 July 2010

Concerned about the negative image being projected elsewhere about the Indian pharmaceutical industry as a hub of spurious drugs, the Commerce Ministry wants to find a permanent solution to the issue by creating some system with the help of the industry or through the Directorate General of Foreign Trade (DGFT), reports the local news service PharmaBiz.com.

At a high-level meeting held recently, Commerce and Trade Secretary Anand Sharma made it clear that he wanted a permanent solution to the problem. He backed an idea presented by the representative of Bilcare Research about introducing a technology on traceability of medicines through radio frequency.

Last month, Pune-based Applied DNA Sciences, provider of DNA-based security solutions, and Bilcare, inventors of the nonClonableID, announced a definitive agreement to market an integrated version of their technologies to provide a unique multi-layered security for brand protection, anti-counterfeiting and logistic and provenance control.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics